Preclinical Medical Device Testing Services Market is expected to reach US$ 6.63 Billion by 2032, at a CAGR of 9% | FMI

The global Preclinical Medical Device Testing Services Market was worth US$ 2.8 billion in 2022 and is expected to be worth US$ 6.63 billion by 2032, growing at a CAGR of 9% during the forecast period.

Preclinical medical device testing services market growth can be attributed to increasing product complexity and stringent government regulations. The market for preclinical medical device testing services grew at a 5.5% CAGR from 2017 to 2021.

Artificial intelligence and the Internet of Things are collaborating to advance preclinical medical device testing services. Furthermore, the rising cost of diagnosing and treating illnesses at an early stage is opening up new potential for the development of preclinical medical device testing services. Manufacturers are also investigating and analyzing preclinical devices in order to fix difficulties with them at an early stage. As a result, the need for preclinical medical device testing services is increasing.

Get a Full PDF Sample Copy of the Latest Reports @ https://www.futuremarketinsights.com/reports/sample/rep-gb-14994

On the contrary, incompatible sterilization methods, along with equipment sensitivity, are impeding the market growth. Furthermore, authorization for experimental medical devices varies by area. As a result, the total market expansion is hampered.

Key Takeaways from the Market Study

  • The global preclinical medical device testing services market is expected to flourish 3x from 2022-2032
  • Microbiology and sterility testing are expected to possess a market share of 35%
  • U.S projected to lead the market by expanding at a CAGR of 18% during the forecast period.
  • India expected to register a CAGR of 13% for preclinical medical device testing services in the assessment period 2022-2032
  • Switzerland to be an emerging hub across Europe, expected to reflect a 10% value CAGR until 2032

“Increasing burden of diseases and strict governmental regulations for the safety of patients is positively influencing the demand for preclinical medical device testing services,” states an FMI analyst.

Have a Conversation with the Analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-14994

Competitive Landscape

  • SGS SA
  • Eurofins Scientific
  • Intertek Group Plc
  • WUXI APPTEC
  • TÜV SÜD AG
  • Sterigenics International LLC
  • Nelson Labs
  • North American Science Associates Inc.
  • Charles River Laboratories International Inc.
  • Pace Analytical Services LLC

Some of the recent key developments among the players are:

  • In February 2022, Eurofins acquired Genetic Testing Service JSC from Vietnam. Through this expansion, the company is planning to expand its presence in Asia and strengthen its global network of advanced genetic testing.
  • In September 2021, Nelson Labs and Sterigenics have collaborated to open a state of art laboratory and expand sterilization facilities to meet growing customer demand in Europe.

Browse the Full Report with Facts and Figures of the Preclinical Medical Device Testing Services Market Report @  https://www.futuremarketinsights.com/checkout/14994

Key Segments Profiled in the Preclinical Medical Device Testing Services Industry Survey

Preclinical Medical Device Testing Services by Service:

  • Biocompatibility Tests
  • Chemistry Test
  • Microbiology & Sterility Testing
    • Bioburden Determination
    • Pyrogen & Endotoxin Testing
    • Sterility Test and Validation
      • Ethylene Oxide (EO) gas sterilization
      • Gamma-irradiation
      • E-beam Sterilization
      • X-ray Sterilization
      • Antimicrobial Activity Testing
      • Others
  • Package Validation

About Future Market Insights (FMI) 

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedInTwitterBlogs

About the Author

Nikhil Kaitwade

Associate Vice President at Future Market Insights, Inc. has over a decade of experience in market research and business consulting. He has successfully delivered 1500+ client assignments, predominantly in Automotive, Chemicals, Industrial Equipment, Oil & Gas, and Service industries.
His core competency circles around developing research methodology, creating a unique analysis framework, statistical data models for pricing analysis, competition mapping, and market feasibility analysis. His expertise also extends wide and beyond analysis, advising clients on identifying growth potential in established and niche market segments, investment/divestment decisions, and market entry decision-making.
Nikhil holds an MBA degree in Marketing and IT and a Graduate in Mechanical Engineering. Nikhil has authored several publications and quoted in journals like EMS Now, EPR Magazine, and EE Times.

Leave a Reply

Your email address will not be published. Required fields are marked *

You may also like these